Back to Search
Start Over
RVX-208 Exploratory Study Illustrates Early Potential for Alzheimer's Disease
- Source :
- Clinical Trials Week. November 24, 2008, 33
- Publication Year :
- 2008
-
Abstract
- Resverlogix Corp. ('Resverlogix') (TSX:RVX) announced that treatment with its lead drug RVX-208, a first in class ApoA-I/Prebeta-HDL elevating drug, in a post-hoc analysis from the Phase 1a clinical trial found [...]
Details
- Language :
- English
- ISSN :
- 15436772
- Database :
- Gale General OneFile
- Journal :
- Clinical Trials Week
- Publication Type :
- News
- Accession number :
- edsgcl.190391642